Why is Sanofi Consumer falling/rising?

As of 30-Jun, Sanofi Consumer Healthcare India Ltd is experiencing a significant rise in its stock price, currently at 5,695.25, reflecting an increase of 689.25 or 13.77%. The stock has reached a new 52-week and all-time high of Rs. 5,954 today, demonstrating strong performance by outperforming its sector by 13.08%. After two consecutive days of decline, the stock has reversed its trend, gaining momentum with an intraday high of Rs. 5,954, indicating high volatility with an intraday fluctuation of 5.93%. Additionally, the stock has shown impressive returns over various periods, including a 14.92% increase over the past week and a 15.41% rise year-to-date, significantly outperforming the Sensex, which has only increased by 2.09% and 7.00% respectively.
In the broader market context, Sanofi's short-term performance is notably stronger than the benchmark, as it has outpaced the Sensex by a considerable margin over the past week and month. However, there are concerns regarding falling investor participation, as evidenced by a 61.11% drop in delivery volume on June 27 compared to the five-day average. Despite this decline in participation, the stock remains liquid enough for trading, suggesting that while investor interest may be fluctuating, the overall market conditions are favorable for Sanofi Consumer. The combination of strong price movements, high volatility, and a positive trend reversal contributes to the stock's rising trajectory.